Southern analysis using human DNA and RNA (Clontech) were performed as described (4). 15. Rabbits were immunized with peptides corresponding to the cytoplasmic domain of either human DAP10 (PAQEDGKVYINMPGRG) (Anaspec, San Jose, CA) or human NKG2D (KKSDFSTRWQKQR) (Research Genetics, Birmingham, AL) (13). Antisera were affinitypurified with the immunizing peptide. Specificity was determined by testing the affinity-purified antibodies by immunoprecipitation and protein immunoblot analysis on Ba/F3 cells transfected with human DAP10 and NKG2D (or both), compared with preimmune sera or control antibodies. 16. Cells were labeled with 125 I and solubilized [1% digitonin, 0.12% Triton X-100, 150 mM NaCl, 20 mM triethanolamine, 0.01% NaN 3 (pH 7.8), and protease inhibitors] (4). Lysates were incubated (2 hours, 4°C) with Pansorbin (Calbiochem) coated with cIg, affinity-purified anti-DAP10, and affinity-purified anti-NKG2D. For immunoprecipitation with mouse mAb, Pansorbin was precoated with rabbit antibody to mouse Ig (Sigma) and mouse NKG2D mAb 5C6, anti-Flag mAb M2 (Sigma), or cIg. Immunoprecipitates were washed in buffer [5 mM CHAPS, 50 mM tris, 150 mM NaCl (pH 8.0), and protease inhibitors] (4). 17. A cDNA containing the human CD8 leader segment, followed by the Flag epitope (DYKDDDDK), and joined to the extracellular, transmembrane, and cytoplasmic segments of human DAP10, was subcloned into the pMX-neo retroviral vector (4, 13). Human NKG2D cDNA (8) was subcloned into pMX-puro. The D-A transmembrane Flag-DAP10 mutant cDNA with an A (GCC) substituted for D (GAT ) and the R-L transmembrane NKG2D mutant cDNA with an L (CT T) substituted for R (CGT ) were generated by PCR mutagenesis. Retroviruses were generated using the Phoenix packaging cell (4). Ba/F3 cells were infected and drug-selected, and transfectants were isolated by flow cytometry (4).
DAP10 and NKG2D (or both), compared with preimmune sera or control antibodies. 16 . Cells were labeled with 125 I and solubilized [1% digitonin, 0.12% Triton X-100, 150 mM NaCl, 20 mM triethanolamine, 0.01% NaN 3 (pH 7.8), and protease inhibitors] (4). Lysates were incubated (2 hours, 4°C) with Pansorbin (Calbiochem) coated with cIg, affinity-purified anti-DAP10, and affinity-purified anti-NKG2D. For immunoprecipitation with mouse mAb, Pansorbin was precoated with rabbit antibody to mouse Ig (Sigma) and mouse NKG2D mAb 5C6, anti-Flag mAb M2 (Sigma) , or cIg. Immunoprecipitates were washed in buffer [5 mM CHAPS, 50 mM tris, 150 mM NaCl (pH 8.0), and protease inhibitors] (4). 17 . A cDNA containing the human CD8 leader segment, followed by the Flag epitope (DYKDDDDK), and joined to the extracellular, transmembrane, and cytoplasmic segments of human DAP10, was subcloned into the pMX-neo retroviral vector (4, 13) . Human NKG2D cDNA (8) was subcloned into pMX-puro. The D-A transmembrane Flag-DAP10 mutant cDNA with an A (GCC) substituted for D (GAT ) and the R-L transmembrane NKG2D mutant cDNA with an L (CT T) substituted for R (CGT ) were generated by PCR mutagenesis. Retroviruses were generated using the Phoenix packaging cell (4) . Ba/F3 cells were infected and drug-selected, and transfectants were isolated by flow cytometry (4).
18. Phosphorylated or unphosphorylated biotinylated peptides of the cytoplasmic domain of DAP10 (PAQEDGKVYINMPGRG) were incubated with lysates from NKL, precipitated with avidin-agarose, and washed [1% NP-40, 50 mM tris, 150 mM NaCl (pH 7.8), and protease inhibitors] (4, 13). Immunoprecipitates were analyzed by protein immunoblot using either anti-p85 or anti-Shc (specificity control) (UBI, Lake Placid, NY ).
NKL and NKG2D-Flag-DAP10
ϩ Ba/F3 cells were incubated with 100 mM pervanadate and lysed (0.875% Brij 97, 0.125% NP-40, 150 mM NaCl, 10 mM tris, and protease and phosphatase inhibitors) (4) . Antigens precipitated with cIg, Flag mAb M2, or NKG2D mAb 5C6 were analyzed by protein immunoblot using horseradish peroxidase (HRP)-conjugated phosphotyrosine mAb 4G10 (UBI) or antiserum to p85 (UBI). 20. We thank M. Robertson, J. P. Houchins, C. Turck, G.
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The generation of cell-mediated immunity against many infectious pathogens involves the production of interleukin-12 (IL-12), a key signal of the innate immune system. Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined. Here it is shown that microbial lipoproteins are potent stimulators of IL-12 production by human macrophages, and that induction is mediated by Toll-like receptors (TLRs). Several lipoproteins stimulated TLR-dependent transcription of inducible nitric oxide synthase and the production of nitric oxide, a powerful microbicidal pathway. Activation of TLRs by microbial lipoproteins may initiate innate defense mechanisms against infectious pathogens.
Besides causing disease, mycobacteria have long been recognized for having powerful immunologic adjuvant activity, augmenting both cell-mediated and humoral immune responses. In 1972, a study of the mechanism of mycobacterial adjuvants demonstrated the induction of "soluble mediators," now known to be cytokines, which mediated the augmentation of immune responses (1 (6 ) . We therefore investigated the mycobacterial products that induce IL-12 as well as the mechanism responsible for its induction.
Mycobacterium tuberculosis H 37 Rv was gamma-irradiated and lysed by mechanical disruption, subcellular fractions were generated (7) and tested for the capacity to induce IL-12 with a human monocyte line, THP-1 (8) . Other than the M. tuberculosis lysate, the soluble cell wall-associated proteins (SCWPs) contained most of the IL-12 p40 -inducing capacity, consistent with the known adjuvant activity of mycobacterial cell walls (Fig. 1A) . The combined cytosolic and membrane protein fraction, the culture filtrate, the lipoglycan from M. tuberculosis, and the mycolyl arabinogalactan peptidoglycan complex were less potent on a per weight basis (9).
To identify the cell wall-associated proteins responsible for IL-12 p40 release, we fractionated the SCWP preparation by gel filtration chromatography and preparative isoelectric focusing and monitored the bioactivity by measuring IL-12 p40 production (10). Subsequent separation of the bioactive fraction by SDS-PAGE indicated four prominently stained proteins: three bands at 17, 21.5, and 39 kD and a doublet at 60 to 70 kD (Fig. 1B) . After these regions were transferred to nitrocellulose, they were solubilized (11) and used to stimulate THP-1 cells. The band migrating to 21.5 kD induced the highest levels of IL-12 p40 release, followed by the 39-kD band, with the two other regions inducing little activity (Fig. 1C) (Fig. 1D) . The ability of the 19-kD lipoprotein to induce IL-12 was independent of tumor necrosis factor-␣ (TNF-␣) release, because neutralizing antibodies to TNF-␣ (anti-TNF-␣) blocked by less than 10% the induction of IL-12 p40 (13). The 19-kD lipoprotein also stimulated IL-12 p70 release from normal human monocytes (14 ). Thus, the M. tuberculosis 19-kD lipoprotein is a major inducer of IL-12, a cytokine that can amplify T H 1 and cytolytic T cell responses and hence contribute to the adjuvant activity of mycobacteria.
We investigated the mechanism by which the 19-kD lipoprotein induces IL-12 by using an IL-12 p40 promoter CAT reporter transiently transfected into the mouse macrophage cell line RAW 264.7 (15, 16) . The 19-kD lipoprotein induced IL-12 p40 promoter activity in a dose-dependent manner and at a level comparable to lipopolysaccharide (LPS) ( Fig. 2A) . Previous studies indicated that LPS induction of IL-12 p40 promoter activity is dependent on both C/EBP and nuclear factor kappa B (NF-B) sites (15, 17) . The ability of both the 19-kD lipoprotein and LPS to induce IL-12 p40 promoter activity was reduced in substitution mutants of the C/EBP and NF-B sites, but was not affected by a mutation in a PU.1-binding site (Fig. 2B) .
Given that the 19-kD lipoprotein induced monocyte IL-12 in a manner analogous to LPS, we reasoned that the cell surface receptor that transduces the signal for the 19-kD lipoprotein may be identical to that for LPS. Because Tolllike receptors (TLRs) have been reported to activate monocyte cytokine production (18) , to bind LPS, and to transduce the proper signal for LPS-stimulated gene activation in monocytes (19) , we hypothesized that the 19-kD lipoprotein could induce IL-12 through TLRs. TLR family members are transmembrane proteins containing repeated leucine-rich motifs in their extracellular portions, similar to other pattern were transiently transfected with a murine IL-12 p40 promoter CAT reporter as described (15, 16) . Transfectants were stimulated with LPS (Salmonella typhosa, Sigma, St. Louis, MO) or 19- 
(B) IL-12 p40 promoter mutations in the NF-B (Ϫ131/Ϫ122) and C/EBP (Ϫ95/Ϫ88) sites blocked LPS (gray, 5 g/ ml) and 19-kD lipoprotein (black, 5 g/ml) stimulated promoter activation. RAW 264.7 cells were transiently transfected as described above with NF-B, C/EBP, and PU.1 mutant constructs, and promoter induction levels were measured by CAT assay (15, 16) . (C) A mutant form of TLR-2 (TLR-2 dn1) lacking 13 amino acids of the COOH-terminal domain inhibits LPS and lipoprotein induction of IL-12 p40 promoter activity. Data reflect at least three independent experiments and are reported as a percentage of antigen-stimulated IL-12 p40 promoter activity cotransfected with a vector control. Lipoproteins and lipopeptides were prepared as described (31) . (D) Monoclonal antibody to TLR-2 blocks LPS-and lipoprotein-induced, but not CD40L trimer-induced, IL-12 p40 production from human adherent monocytes (28, 38, 41) . recognition proteins of the innate immune system. TLR proteins also contain a cytoplasmic domain that is homologous to the signaling domain of the IL-1 receptor and can activate a signaling pathway that includes activation of NF-B and subsequent gene transcription (19, 20) . We investigated the role of TLR in 19-kD lipoprotein-induced IL-12 production by cotransfecting the RAW 264.7 macrophage cell line with a TLR-2 dominant negative mutant containing a truncation of 13 amino acids at the COOH-terminus (19) , along with the IL-12 p40 promoter construct (16) . Transfection of various amounts of the TLR-2 dominant negative mutant (TLR-2 dn1) inhibited both 19-kD lipoprotein-and LPS-induced IL-12 p40 promoter activation relative to a vector control (Fig. 2C) . Activity was not inhibited by transfection of a vector containing a control gene, IL-1R (21).
The 19-kD M. tuberculosis lipoprotein is a member of a family of prokaryotic lipoproteins. Lipoproteins have been found extensively in both Gram-positive and Gram-negative bacteria, including Treponema pallidum, Mycoplasma species, and Borrelia burgdorferi (22) (23) (24) . Profound immunoregulatory functions have been attributed to lipoproteins, including monocyte or macrophage activation (25) . The portion of lipoprotein responsible for its immunologic activity is located in the NH 2 -terminal triacylated lipopeptide region. Removal of this lipid element rendered the parent product nonactivating, and synthetic lipopeptides could activate B cells and macrophages (23, 24, 26) . Studies of the B. burgdorferi OspA lipoprotein and the 47-kD lipopeptide of T. pallidum demonstrated lipoprotein induction of IL-12 mRNA (24, 27) . We found that OspA and the NH 2 -terminal lipopeptide of the T. pallidum 47-kD antigen activated IL-12 p40 promoter activity by a TLR-dependent mechanism (Fig. 2C) , thereby providing evidence that TLRs serve to recognize a diverse family of microbial lipoproteins. A monoclonal antibody specific to human TLR-2 (28) blocked the ability of LPS and the 19-kD lipoprotein to stimulate IL-12 production from primary human monocytes, indicating the crucial role for TLR-2 in monocyte activation by these microbial molecules (Fig. 2D) . Because the deacylated OspA (d-OspA) was unable to activate IL-12 production from THP-1 cells (29), the fatty acyl moiety, which is genetically and structurally conserved among microbial lipoproteins, appears to be crucial for monocyte activation through TLRs.
Having shown that TLRs are necessary for gene activation by lipoproteins, we sought to learn whether TLRs are also sufficient. Using HEK 293 cells, we transfected the NF-Bresponsive ELAM enhancer, because activated NF-B is required for IL-12 p40 promoter activity. HEK 293 cells do not express TLR-2, nor could they be activated by LPS or microbial lipoproteins, as determined by examination of NF-B induction (Fig. 3A) (19, 30) . In contrast, in stable transfectants of HEK 293 cells expressing TLR-2, microbial lipoproteins induced NF-B in a dose-dependent manner and at levels comparable to those induced by LPS. Activation by lipoproteins was enhanced by cotransfection with a CD14 expression vector to levels analogous to LPS induction and consistent with the role of CD14 in facilitating lipoprotein activity (30 -32) (Fig. 3B) . Activation through TLR-2 by lipoproteins was dependent on fatty acyl moieties because deacylated forms of OspA and T. pallidum lipopeptide (d-Tp47) had no activity (Fig. 3C) . Although the data indicate that TLR-2 can mediate gene activation by microbial lipoproteins, the data do not preclude a contributory role for other TLR family members (33) .
To determine whether the TLR signaling pathway stimulated by microbial lipoproteins could be linked to a known macrophage antimicrobial mechanism, we investigated whether the M. tuberculosis lipoprotein could activate gene transcription for inducible nitric oxide synthase (iNOS), given the critical role of iNOS in the production of nitric oxide from macrophages, currently the only effective macrophage mycobactericidal mechanism known in vitro and in vivo (34) . Analysis of gene-disrupted mice revealed that this mechanism was necessary for protection against M. tuberculosis (35). The 19-kD and OspA lipoproteins induced iNOS promoter activity in the RAW 264.7 macrophage cell line (16, 36) . Again, activation was dependent on the fatty acyl moieties, because d-OspA had no activity (Fig.  4A) . Cotransfection with the TLR-2 dominant negative mutant inhibited the ability of lipoproteins to induce the iNOS promoter (Fig. 4B) , thereby suggesting a role for TLRs in the activation of iNOS by microbial pathogens. Stimulation of monocytes with the 19-kD antigen also induced production of nitric oxide (37).
The presence of Toll in Drosophila indicates that Toll proteins represent a host defense mechanism that has been conserved over hundreds of millions of years of evolution. In mammals, TLRs provide the innate immune system with the ability to react to a spectrum of microbial pathogens expressing lipoproteins and lipopolysaccharides. Animals with altered TLRs manifest increased susceptibility to infection (33) . Our data indicate that TLRs can activate innate immune responses including the generation of NO, a direct microbicidal mechanism, and provide an early signal for induction of IL-12, which functions as a biologic adjuvant amplifying acquired T cell responses to pathogens. Under certain conditions, the TLR signaling pathway can lead to apoptosis of the target cells resulting in down-regulation of the immune response or pathology to the host (28) . It should be possible, however, to develop strategies to stimulate TLRs in order to activate antimicrobial defense mechanisms and to amplify immune responses to a variety of antigens in vaccines. berculosis lysate and various subcellular fractions in a range of concentrations from 0.1 to 10 g/ml. Cellfree supernatants were collected at 20 hours and assayed for IL-12 p40 by enzyme-linked immunosorbent assay (ELISA) (Pharmingen, San Diego, CA). THP-1 cells were plated at a concentration of 2 ϫ 10 5 cells/well in 96-well plates. The cells were cultured in the presence of various M. tuberculosis preparations at 37°C in a CO 2 incubator with RPMI 1640 and 10% heat-inactivated fetal bovine serum (FBS). Cell-free supernatants were harvested 20 hours later and stored at Ϫ20°C until assayed for cytokine concentrations by ELISA as previously described (38, 39) . The amount of lipopolysaccharide in all preparations was measured quantitatively with a Limulus Amoebocyte Lysate assay (Whittaker Bioproducts, Walkersville, MD) and found to be Ͻ40 pg per microgram of M. tuberculosis fraction or protein, an amount that did not stimulate IL-12 activity by itself. 9. The mycolyl arabinogalactan peptidoglycan complex (mAGP) was also derived from the cell wall pellet after SDS detergent extraction. Most of the IL-12 p40 -inducing activity was associated with the SCWP fraction compared with mAGP (see supplementary material available at www.sciencemag.org/feature/ data/1040444.shl). Because macrophage phagocytosis of protein-adsorbed particulate suspensions has been reported to induce IL-12 release, we filtered both fractions through a 0.2-m sterile filter. The SCWP fraction retained most of its IL-12 p40 -inducing activity after filtration, whereas the mAGP suspension did not induce IL-12 p40. 10. Cell wall-associated proteins were obtained by suspending the cell wall pellet at a concentration of 1 mg of protein per milliliter of phosphate-buffered saline (PBS) (pH 7.4) containing 2% SDS. The proteins were extracted for 2 hours at room temperature followed by centrifugation at 27,000g for 30 min.
The supernatant was applied to a Sephacryl S-200 column, and proteins were eluted at a flow rate of 0.5 ml/min with PBS (pH 7.4), 2% SDS. Fractions were pooled on the basis of the relative molecular weight of the products as determined by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and SDS was removed. Specific pools of size-fractionated SCWP were further purified by preparative isoelectric focusing. Specifically, the desired fractions were dialyzed against 4 M urea, 10% glycerol and brought to a final volume of 50 ml with the same. NP-40 was then added to a final concentration of 1%, and Pharmalytes pH 5-7 and pH 3-10 were added to a final concentration of 4 and 1%, respectively. This suspension was loaded into a 50-ml Rotofor cell (BioRad Laboratories, Hercules, CA) and electrophoresed with 15-W constant power for 4 hours. Fractions were collected, dialyzed against 100 mM NH 4 HCO 3 , and stored at Ϫ20°C. The fractions were loaded onto a 13.5% preparative SDS-polyacrylamide gel (16 cm by 20 cm by 1.5 mm) and electrophoresed at 20 mA for 1.5 hours. The resolved proteins were visualized by using Coomassie Brilliant Blue R250, excised from the gel, and electroeluted with a BioRad 422 ElectroEluter with 50 mM NH 4 HCO 3 . At each step, fractions were tested for their ability to induce IL-12 p40, and the fractions with potent activity were further purified. Rotofor fraction number 4 was electrophoresed under denaturing conditions on a 4 to 20% trisglycine minigel and transferred to nitrocellulose. Areas containing the four protein bands noted in Fig. 1B were isolated and solubilized as described previously (11) 
